< Major Announcements After Market Close >


◆ InBody = Q1 operating profit of 5.6 billion KRW… down 14% YoY


◆ CJ Freshway = Q1 operating loss of 12.6 billion KRW… turned to deficit


◆ Sollid = Decision to issue 10 billion KRW private CB


◆ SFC = Korea Exchange "SFC delisting resolution"


◆ Gamevil = Q1 operating profit of 6.2 billion KRW… turned to profit YoY



◆ Samchundang Pharmaceutical = Approval of Phase 3 clinical trial plan for Eylea biosimilar


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing